Related Experiment Videos
[Surgical treatment of angina pectoris]
1Servicio de Cirugía Cardíaca, Hospital Universitario Virgen de las Nieves, Granada.
Insights
Coronary artery bypass grafting effectively relieves angina and prolongs life. Modern challenges include competing with less invasive procedures for older patients with complex conditions.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
Context:
- Coronary artery bypass grafting (CABG) remains a cornerstone therapy for angina pectoris.
- Patient profiles undergoing CABG are shifting towards older individuals with complex comorbidities and extensive coronary artery disease.
- Percutaneous coronary interventions (PCI) have evolved, altering the landscape for surgical candidates.
Purpose:
- To review the current role and evolving challenges of coronary artery bypass grafting in the era of percutaneous revascularization.
- To analyze randomized trials comparing CABG with angioplasty, particularly for multivessel coronary artery disease.
- To explore emerging trends aimed at improving the cost-effectiveness and invasiveness of coronary artery bypass grafting.
Summary:
- Coronary artery bypass grafting (CABG) is a highly effective treatment for angina and can prolong life in select patient groups.
- The increasing complexity of patients undergoing CABG presents challenges in maintaining outcomes and cost-effectiveness against percutaneous coronary intervention (PCI).
- Key randomized trials comparing CABG to angioplasty, especially for multivessel disease, are examined, alongside innovations to make CABG less invasive and more economical.
Impact:
- Highlights the need for continued innovation in coronary artery bypass grafting to maintain its efficacy and competitiveness.
- Provides insights into patient selection and treatment strategies for multivessel coronary artery disease.
- Informs future research and clinical practice regarding the optimization of coronary revascularization procedures.
Abstract:
Coronary artery bypass grafting is a very effective therapy for the relief of angina pectoris. It has been demonstrated that, in certain subsets of patients, it prolongs life when compared to other treatment options. However, the introduction and development of less invasive percutaneous procedures has changed the profile of patients subject to coronary surgery. They are older, with more extensive coronary disease and comorbid conditions. The challenge of coronary artery bypass grafting is to maintain the excellent results obtained tha far and to compete with percutaneous revascularization procedures regarding morbidity and cost-effectiveness. We review the most important randomized trials of coronary surgery, especially those which consider its role in multivessel disease versus angioplasty and the new trends that try to make it cheaper and less invasive.